This report contains market size and forecasts of Oral Hypoglycemic Drugs in global, including the following market information:
Global Oral Hypoglycemic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Hypoglycemic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Oral Hypoglycemic Drugs companies in 2021 (%)
The global Oral Hypoglycemic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sulfonylureas (SU) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Hypoglycemic Drugs include Pfizer, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Merck & Co, Eli Lilly, Sanofi, Takeda Pharmaceuticals and Novo Nordisk, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Hypoglycemic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Hypoglycemic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Hypoglycemic Drugs Market Segment Percentages, by Type, 2021 (%)
Sulfonylureas (SU)
Double Guanidine
Glucosidase Inhibitor
Insulin Synergist
Global Oral Hypoglycemic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Hypoglycemic Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Oral Hypoglycemic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Hypoglycemic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Hypoglycemic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Hypoglycemic Drugs revenues share in global market, 2021 (%)
Key companies Oral Hypoglycemic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Oral Hypoglycemic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Johnson & Johnson
GlaxoSmithKline
Merck & Co
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb